Sensei Biotherapeutics Files 2025 Proxy Statement
Ticker: SNSE · Form: DEF 14A · Filed: Apr 11, 2025 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | DEF 14A |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
Sensei Bio filed its proxy statement for the 2025 shareholder meeting. Vote on directors & company proposals.
AI Summary
Sensei Biotherapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 11, 2025, for its 2025 annual meeting of stockholders. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key details regarding director nominations and other corporate matters will be presented for shareholder approval.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and strategic direction at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine annual filing providing information to shareholders and does not inherently present new financial or operational risks.
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- 0000950170-25-053033 (filing_id) — Accession Number
- 20250411 (date) — Filing Date
- 20250521 (date) — Conformed Period of Report
- 1405 Research Blvd, Suite 125, Rockville, MD 20850 (address) — Company Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important corporate matters, such as the election of directors, executive compensation, and other proposals, typically in advance of an annual meeting.
When was this proxy statement filed?
Sensei Biotherapeutics, Inc. filed this definitive proxy statement on April 11, 2025.
What is the fiscal year end for Sensei Biotherapeutics, Inc.?
The fiscal year end for Sensei Biotherapeutics, Inc. is December 31 (1231).
What is the company's Standard Industrial Classification (SIC) code?
The SIC code for Sensei Biotherapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for Sensei Biotherapeutics, Inc.?
The SEC file number for Sensei Biotherapeutics, Inc. is 001-39980.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 11, 2025 regarding Sensei Biotherapeutics, Inc. (SNSE).